Utility for Postoperative Respiratory Function of Transmediastinal Esophagectomy for Esophageal Carcinoma

In Vivo. 2024 Sep-Oct;38(5):2358-2363. doi: 10.21873/invivo.13702.

Abstract

Background/aim: Esophagectomy for esophageal carcinoma (EC) is known to lead to deterioration of respiratory function (RF) due to thoracotomy and mediastinal lymph node dissection. This study aimed to evaluate the impact of transmediastinal esophagectomy (TME) on pulmonary function.

Patients and methods: We retrospectively analyzed the data of 102 patients with EC who underwent transthoracic esophagectomy (TTE) or TME and underwent RF tests within three months postoperatively at Kyoto Prefectural University of Medicine between 2014 and 2022. Perioperative pulmonary functions were evaluated based on vital capacity (VC) and forced expiratory volume in one second (FEV1.0).

Results: Among 102 patients undergoing esophagectomy, 12 (11.8%) patients were included in the TTE group, and the remaining 90 (88.2%) patients were included in the TME group. Neoadjuvant treatments were significantly more common in the TTE group (p=0.011), with more advanced tumor stages (p=0.017). The TME group had significantly lower estimated blood loss (p=0.015). RF after esophagectomy showed a decrease in VC, and VC of predicted (%VC). The decrease rate in VC, %VC, and FEV1.0 was significantly greater in the TTE group than in the TME group.

Conclusion: TME is a surgical procedure with a less severe postoperative decline in RF than TTE.

Keywords: Esophageal cancer; esophagectomy; respiratory function.

MeSH terms

  • Aged
  • Esophageal Neoplasms* / physiopathology
  • Esophageal Neoplasms* / surgery
  • Esophagectomy* / adverse effects
  • Esophagectomy* / methods
  • Female
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Postoperative Complications / etiology
  • Postoperative Period
  • Respiratory Function Tests
  • Retrospective Studies
  • Treatment Outcome